Protein Tyrosine Phosphatases, Non-Receptor
"Protein Tyrosine Phosphatases, Non-Receptor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subcategory of protein tyrosine phosphatases that occur in the CYTOPLASM. Many of the proteins in this category play a role in intracellular signal transduction.
MeSH Number(s)
D08.811.277.352.650.775.300
D12.644.360.585
D12.776.476.564
Concept/Terms
Protein Tyrosine Phosphatases, Non-Receptor- Protein Tyrosine Phosphatases, Non-Receptor
- Protein Tyrosine Phosphatases, Non Receptor
- Non-Transmembrane Protein Tyrosine Phosphatases
- Non Transmembrane Protein Tyrosine Phosphatases
Below are MeSH descriptors whose meaning is more general than "Protein Tyrosine Phosphatases, Non-Receptor".
Below are MeSH descriptors whose meaning is more specific than "Protein Tyrosine Phosphatases, Non-Receptor".
- Protein Tyrosine Phosphatases, Non-Receptor
- Protein Tyrosine Phosphatase, Non-Receptor Type 1
- Protein Tyrosine Phosphatase, Non-Receptor Type 11
- Protein Tyrosine Phosphatase, Non-Receptor Type 12
- Protein Tyrosine Phosphatase, Non-Receptor Type 13
- Protein Tyrosine Phosphatase, Non-Receptor Type 2
- Protein Tyrosine Phosphatase, Non-Receptor Type 22
- Protein Tyrosine Phosphatase, Non-Receptor Type 3
- Protein Tyrosine Phosphatase, Non-Receptor Type 4
- Protein Tyrosine Phosphatase, Non-Receptor Type 6
This graph shows the total number of publications written about "Protein Tyrosine Phosphatases, Non-Receptor" by people in Harvard Catalyst Profiles by year, and whether "Protein Tyrosine Phosphatases, Non-Receptor" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 4 | 0 | 4 |
| 2010 | 2 | 0 | 2 |
| 2011 | 4 | 0 | 4 |
| 2012 | 4 | 2 | 6 |
| 2013 | 3 | 1 | 4 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 1 | 3 |
| 2017 | 4 | 2 | 6 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
Below are the most recent publications written about "Protein Tyrosine Phosphatases, Non-Receptor" by people in Profiles.
-
X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition. Acta Neuropathol. 2022 09; 144(3):537-563.
-
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell. 2021 09 16; 184(19):4919-4938.e22.
-
Recurrent PTPN14 Mutations in Trichilemmoma: Evidence for Distinct Pathways of Molecular Pathogenesis. Am J Dermatopathol. 2022 Aug 01; 44(8):545-552.
-
Ptpn21 Controls Hematopoietic Stem Cell Homeostasis and Biomechanics. Cell Stem Cell. 2019 04 04; 24(4):608-620.e6.
-
miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Oncogene. 2019 04; 38(16):2923-2936.
-
Mutations of PTPN23 in developmental and epileptic encephalopathy. Hum Genet. 2017 11; 136(11-12):1455-1461.
-
STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice. Neuropharmacology. 2018 Jan; 128:43-53.
-
A novel EPM2A mutation in a patient with Lafora disease presenting with early parkinsonism symptoms in childhood. Seizure. 2017 Oct; 51:77-79.
-
Long-term effects of systemic gene therapy in a canine model of myotubular myopathy. Muscle Nerve. 2017 Nov; 56(5):943-953.
-
The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7. J Virol. 2017 04 01; 91(7).